New Oral IL-23 Receptor Antagonist Peptide Effective in PASI Reduction for Psoriasis
These new data highlight the efficacy of JNJ-77242113 as a potential oral therapy option for moderate-to-severe psoriasis patients.
Stay updated with breaking news from Peptide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
These new data highlight the efficacy of JNJ-77242113 as a potential oral therapy option for moderate-to-severe psoriasis patients.
The note introduces Quantum-Si's Platinum, which offers an innovative solution to directly sequencing proteins
Using interactions between viral peptides and human proteins as a starting point, researchers from Enyo Pharma Inc., the University of Lyon and other institutions were able to bootstrap themselves to a mitochondria-targeting small molecule that showed activity in a mouse model of nonalcoholic steatohepatitis (NASH) with chronic kidney disease.
Peptide-Pilot™ reduces peptide production from weeks to just hours Cutting-edge Solid Phase Peptide Synthesiser (SPPS) from Vapourtec drastically shortens drug development cycles, reducing production times for target peptides from weeks to under a day compared to conventional batch methods at room temperature. Click to read more...
Swedish bioanalyticals provider Gyros Protein Technologies AB (part of Mesa Labs) and global life sciences company Biotage have jointly developed an automated plate-based peptide purification workflow to provide a fast and environmentally sustainable solution for high-throughput peptide purification. Click to read more...